Non ci sono recensioni
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.
Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Background on Bladder Cancer
Pages 3-3
Goonewardene, Sanchia S. (et al.)
Introduction to Bladder Cancer Type and Therapy
Pages 5-6
Goonewardene, Sanchia S. (et al.)
Histological Variants in Bladder Cancer—Sqaumous Cell Carcinoma and Squamous Differentiation
Pages 9-10
Goonewardene, Sanchia S. (et al.)
Histological Variants in Bladder Cancer—Adenocarcinoma
Pages 11-15
Goonewardene, Sanchia S. (et al.)
Histological Variants in Bladder Cancer—Sarcomatoid Differentiation
Pages 17-19
Goonewardene, Sanchia S. (et al.)
Histological Variants in Bladder Cancer—Carcinosarcoma
Pages 21-25
Goonewardene, Sanchia S. (et al.)
Histological Variants in Bladder Cancer—Small Cell Carcinoma
Pages 27-34
Goonewardene, Sanchia S. (et al.)
Histological Variants—Plasmacytoid Bladder Cancer
Pages 35-41
Goonewardene, Sanchia S. (et al.)
Introduction to Epidemiology of Bladder Cancer
Pages 45-47
Goonewardene, Sanchia S. (et al.)
Epidemiology, Risk Factors and Occupational Hazards—A Systematic Review
Pages 49-51
Goonewardene, Sanchia S. (et al.)
Systematic Review Results on Bladder Cancer Epidemiology, Occupational Hazards and Risk Factors
Pages 53-61
Goonewardene, Sanchia S. (et al.)
Bladder Cancer—Diagnostic Pathways
Pages 65-67
Goonewardene, Sanchia S. (et al.)
Systematic Review Method—Bladder Cancer Screening
Pages 69-71
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Screening—Systematic Review Results
Pages 73-98
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Screening Systematic Review Conclusion
Pages 99-101
Goonewardene, Sanchia S. (et al.)
Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening
Pages 103-104
Goonewardene, Sanchia S. (et al.)
Usefulness of Screening in Bladder Cancer
Pages 105-107
Goonewardene, Sanchia S. (et al.)
Management of Non-Muscle Invasive Bladder Cancer
Pages 111-113
Goonewardene, Sanchia S. (et al.)
A New Technique—En Bloc Resection of Bladder Tumours
Pages 115-116
Goonewardene, Sanchia S. (et al.)
Prognostic Factors for Endoscopic Resection in NMIBC
Pages 117-118
Goonewardene, Sanchia S. (et al.)
NMIBC and Oncological Outcomes from Endoscopic Resection
Pages 119-120
Goonewardene, Sanchia S. (et al.)
Recurrence in NMIBC
Pages 121-122
Goonewardene, Sanchia S. (et al.)
Definitive Treatment in NMIBC
Pages 123-124
Goonewardene, Sanchia S. (et al.)
A Systematic Review of En-Bloc Resection
Pages 125-127
Goonewardene, Sanchia S. (et al.)
Systematic Review—Results from En-Bloc Resection of Bladder Cancer
Pages 129-139
Goonewardene, Sanchia S. (et al.)
NMIBC—Fulguration in Low Risk Disease
Pages 143-144
Goonewardene, Sanchia S. (et al.)
Active Surveillance in Non-Muscle Invasive Bladder Cancer
Pages 145-150
Goonewardene, Sanchia S. (et al.)
Hyperthermic MMC—A Systematic Review
Pages 151-164
Goonewardene, Sanchia S. (et al.)
Literature Related to Hyperthermic MMC
Pages 165-166
Goonewardene, Sanchia S. (et al.)
BCG—Patterns of Administration
Pages 169-170
Goonewardene, Sanchia S. (et al.)
NMIBC—BCG Strain and Outcomes
Pages 171-172
Goonewardene, Sanchia S. (et al.)
Adverse Effects in BCG Therapy
Pages 173-174
Goonewardene, Sanchia S. (et al.)
BCG and Elderly Patients
Pages 175-179
Goonewardene, Sanchia S. (
A Systematic Review of NMIBC and Intravesical Chemotherapy
Pages 181-183
A Systematic Review of NMIBC and Intravesical Chemotherapy—Results
Pages 185-196
What the Literature Says Re BCG
Pages 197-199
Goonewardene, Sanchia S. (et al.)
Prognostic Factors in BCG
Pages 201-202
Goonewardene, Sanchia S. (et al.)
Intermediate and High Risk NMIBC and BCG
Pages 203-204
Goonewardene, Sanchia S. (et al.)
NMIBC, Low Dose BCG and High-Risk Disease
Pages 205-206
Goonewardene, Sanchia S. (et al.)
Alternatives to BCG Therapy—MMC
Pages 207-208
Goonewardene, Sanchia S. (et al.)
BCG Versus Mitomycin C—A Systematic Review
Pages 209-220
Goonewardene, Sanchia S. (et al.)
What the Literature Says NMIBC—BCG or MMC
Pages 221-222
Goonewardene, Sanchia S. (et al.)
NMIBC and Intravesical Chemotherapy—HIVEC I and HIVEC II
Pages 223-224
Goonewardene, Sanchia S. (et al.)
BCG Refractory Disease—Oncological Outcomes
Pages 225-227
Goonewardene, Sanchia S. (et al.)
NMIBC—High Grade BCG Refractory Disease
Pages 229-231
Goonewardene, Sanchia S. (et al.)
A Systematic Review on Alternatives in BCG Refractory Disease
Pages 233-234
Systematic Review Results on BCG Refractory Disease Management
Pages 235-249
Goonewardene, Sanchia S. (et al.)
What the Literature Says on BCG Refractory Disease and Alternatives
Pages 251-252
Goonewardene, Sanchia S. (et al.)
NMIBC—BCG Refractory Disease and Use of Interferon
Pages 253-253
Goonewardene, Sanchia S. (et al.)
Novel Agents in BCG Refractory Disease
Pages 255-259
Goonewardene, Sanchia S. (et al.)
A Scoring System for Intravesical Therapy and NMIBC
Pages 261-261
Goonewardene, Sanchia S. (et al.)
High Risk NMIBC and TURBT
Pages 263-264
Goonewardene, Sanchia S. (et al.)
G3T1 Bladder Cancer: Cystectomy Versus BCG
Pages 265-267
Goonewardene, Sanchia S. (et al.)
A Systematic Review of High-Grade Bladder Cancer—Methods
Pages 269-270
Goonewardene, Sanchia S. (et al.)
Systematic Review of G3T1 Bladder Cancer
Pages 271-281
Goonewardene, Sanchia S. (et al.)
Radical Cystectomy in High Grade NMI Bladder Cancer
Pages 283-284
Goonewardene, Sanchia S. (et al.)
Bladder Cancer in the Elderly
Pages 287-290
Goonewardene, Sanchia S. (et al.)
Systematic Review on Bladder Cancer Management in Elderly Patients
Pages 291-293
Goonewardene, Sanchia S. (et al.)
Systematic Review—Results on Bladder Cancer Management in the Elderly
Pages 295-306
Goonewardene, Sanchia S. (et al.)
Reviews Relating to Management of Bladder Cancer in the Elderly
Pages 307-309
Goonewardene, Sanchia S. (et al.)
Female Outcomes in Bladder Cancer
Pages 311-312
Goonewardene, Sanchia S. (et al.)
A Systematic Review on Bladder Cancer and Female Gender
Pages 313-314
Goonewardene, Sanchia S. (et al.)
Systematic Review Results on Bladder Cancer and Female Gender
Pages 315-320
Goonewardene, Sanchia S. (et al.)
Reviews on Female Gender and Bladder Cancer
Pages 321-322
Goonewardene, Sanchia S. (et al.)
Definition of Bladder Cancer Survivorship
Pages 325-326
Goonewardene, Sanchia S. (et al.)
The Impact of Bladder Cancer Survivorship
Pages 327-327
Goonewardene, Sanchia S. (et al.)
Unmet Needs in Bladder Cancer Survivorship
Pages 329-330
Goonewardene, Sanchia S. (et al.)
Systematic Review—Bladder Cancer Survivorship—Unmet Needs
Pages 331-332
Goonewardene, Sanchia S. (et al.)
Systematic Review Search Results—Bladder Cancer Survivorship and Unmet Need
Pages 333-340
Goonewardene, Sanchia S. (et al.)
Survivorship Challenges in Non-Muscle Invasive Bladder Cancer
Pages 341-343
Goonewardene, Sanchia S. (et al.
Bladder Cancer Survivorship Care Plans
Pages 345-347
Research Summary—A New Model of Care for Patients with Bladder Cancer (MODA)
Pages 349-351
Goonewardene, Sanchia S. (et al.)
What Is the Impact of Sexual and Emotional Concerns on Patients Post Surgery for Patients with Bladder Cancer?
Pages 353-354
Goonewardene, Sanchia S. (et al.)
Results—Telephone Interviews with Thematic Analyses
Pages 355-355
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 1 Erectile Dysfunction
Pages 357-358
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 2 Age Related Disease
Pages 359-359
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 3 Side Effects Post Operatively
Pages 361-362
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact
Pages 363-363
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 5 Impact of Operation on General Health
Pages 365-365
Goonewardene, Sanchia S. (et al.)
Bladder Cancer Survivorship Tool
Pages 367-369
Goonewardene, Sanchia S. (et al.)
Health Related Quality of Life Measurements in Bladder Cancer Survivorship
Pages 371-374
Goonewardene, Sanchia S. (et al.)
Sei sicuro di voler eseguire questa azione?